{
    "Alopecia areata": {
        "Primary organ/body part affected": "Hair follicles",
        "Autoantibodies": "None specific",
        "Acceptance as an autoimmune disease": "Confirmed",
        "Prevalence rate (US)": "2.1%"
    },
    "Autoimmune angioedema": {
        "Primary organ/body part affected": "Skin",
        "Autoantibodies": "C1 inhibitor",
        "Acceptance as an autoimmune disease": "Probable",
        "Prevalence rate (US)": "Less than 5,000"
    },
    "Autoimmune progesterone dermatitis": {
        "Primary organ/body part affected": "Skin",
        "Autoantibodies": "Progesterone",
        "Acceptance as an autoimmune disease": "Probable",
        "Prevalence rate (US)": "Extremely rare"
    },
    "Autoimmune urticaria": {
        "Primary organ/body part affected": "Skin",
        "Autoantibodies": "IgG against IgE or IgE receptor",
        "Acceptance as an autoimmune disease": "Probable",
        "Prevalence rate (US)": "Not well established"
    },
    "Bullous pemphigoid": {
        "Primary organ/body part affected": "Skin",
        "Autoantibodies": "Anti-BP180, Anti-BP230",
        "Acceptance as an autoimmune disease": "Confirmed",
        "Prevalence rate (US)": "6-30 per 100,000 (mostly older adults)"
    },
    "Cicatricial pemphigoid": {
        "Primary organ/body part affected": "Mucous membranes, sometimes skin",
        "Autoantibodies": "Anti-BP180, Anti-BP230",
        "Acceptance as an autoimmune disease": "Confirmed",
        "Prevalence rate (US)": "Rare"
    },
    "Dermatitis herpetiformis": {
        "Primary organ/body part affected": "Skin",
        "Autoantibodies": "Anti-tissue transglutaminase",
        "Acceptance as an autoimmune disease": "Confirmed",
        "Prevalence rate (US)": "10 per 100,000"
    },
    "Dermatomyositis": {
        "Primary organ/body part affected": "Skin and muscles",
        "Autoantibodies": "Anti-Jo1, Anti-Mi2, Anti-SRP, Anti-TIF1",
        "Acceptance as an autoimmune disease": "Confirmed",
        "Prevalence rate (US)": "9 in 1,000,000"
    },
    "Discoid lupus erythematosus": {
        "Primary organ/body part affected": "Skin",
        "Autoantibodies": "ANA, Anti-dsDNA, Anti-Sm",
        "Acceptance as an autoimmune disease": "Confirmed",
        "Prevalence rate (US)": "Part of SLE prevalence (20-150 per 100,000)"
    },
    "Epidermolysis bullosa acquisita": {
        "Primary organ/body part affected": "Skin",
        "Autoantibodies": "Anti-type VII collagen",
        "Acceptance as an autoimmune disease": "Confirmed",
        "Prevalence rate (US)": "Extremely rare"
    },
    "Erythema nodosum": {
        "Primary organ/body part affected": "Skin",
        "Autoantibodies": "None specific",
        "Acceptance as an autoimmune disease": "Possible",
        "Prevalence rate (US)": "Not well established"
    },
    "Gestational pemphigoid": {
        "Primary organ/body part affected": "Skin",
        "Autoantibodies": "Anti-BP180, Anti-BP230",
        "Acceptance as an autoimmune disease": "Confirmed",
        "Prevalence rate (US)": "Rare"
    },
    "Hidradenitis suppurativa": {
        "Primary organ/body part affected": "Skin",
        "Autoantibodies": "None specific",
        "Acceptance as an autoimmune disease": "Uncertain",
        "Prevalence rate (US)": "1-4%"
    },
    "Lichen planus": {
        "Primary organ/body part affected": "Skin, mucous membranes",
        "Autoantibodies": "None specific",
        "Acceptance as an autoimmune disease": "Probable",
        "Prevalence rate (US)": "1%"
    },
    "Lichen sclerosus": {
        "Primary organ/body part affected": "Skin",
        "Autoantibodies": "None specific",
        "Acceptance as an autoimmune disease": "Probable",
        "Prevalence rate (US)": "Rare"
    },
    "Linear IgA disease": {
        "Primary organ/body part affected": "Skin",
        "Autoantibodies": "Anti-epidermal basement membrane IgA",
        "Acceptance as an autoimmune disease": "Confirmed",
        "Prevalence rate (US)": "Extremely rare"
    },
    "Morphea": {
        "Primary organ/body part affected": "Skin",
        "Autoantibodies": "None specific",
        "Acceptance as an autoimmune disease": "Probable",
        "Prevalence rate (US)": "Not well established"
    },
    "Psoriasis": {
        "Primary organ/body part affected": "Skin",
        "Autoantibodies": "Various, not specific",
        "Acceptance as an autoimmune disease": "Confirmed",
        "Prevalence rate (US)": "2-3%"
    },
    "Pemphigus vulgaris": {
        "Primary organ/body part affected": "Skin and mucous membranes",
        "Autoantibodies": "Anti-desmoglein 3, Anti-desmoglein 1",
        "Acceptance as an autoimmune disease": "Confirmed",
        "Prevalence rate (US)": "1-5 per 100,000"
    },
    "Scleroderma (systemic sclerosis)": {
        "Primary organ/body part affected": "Skin, organs",
        "Autoantibodies": "ANA, anti-Scl-70, anti-centromere",
        "Acceptance as an autoimmune disease": "Confirmed",
        "Prevalence rate (US)": "240 per 1,000,000"
    },
    "Vitiligo": {
        "Primary organ/body part affected": "Skin",
        "Autoantibodies": "Various, not specific",
        "Acceptance as an autoimmune disease": "Confirmed",
        "Prevalence rate (US)": "1%"
    },
    "Autoimmune enteropathy": {
        "Primary organ/body part affected": "Small intestine",
        "Autoantibodies": "Anti-enterocyte antibodies",
        "Acceptance as an autoimmune disease": "Probable",
        "Prevalence rate (US)": "Rare"
    },
    "Autoimmune hepatitis": {
        "Primary organ/body part affected": "Liver",
        "Autoantibodies": "ANA, ASMA, anti-LKM1",
        "Acceptance as an autoimmune disease": "Confirmed",
        "Prevalence rate (US)": "1 in 10,000 to 1 in 50,000"
    },
    "Celiac disease": {
        "Primary organ/body part affected": "Small intestine",
        "Autoantibodies": "Anti-tissue transglutaminase antibodies (tTG), Endomysial antibody (EMA), Deamidated gliadin peptide (DGP)",
        "Acceptance as an autoimmune disease": "Confirmed",
        "Prevalence rate (US)": "1 in 100"
    },
    "Crohn's disease": {
        "Primary organ/body part affected": "Digestive tract",
        "Autoantibodies": "ASCA, Anti-OmpC, Anti-CBir1, ANCA",
        "Acceptance as an autoimmune disease": "Probable",
        "Prevalence rate (US)": "201 per 100,000 adults"
    },
    "Pernicious anemia": {
        "Primary organ/body part affected": "Stomach",
        "Autoantibodies": "Anti-IF, Anti-parietal cell",
        "Acceptance as an autoimmune disease": "Confirmed",
        "Prevalence rate (US)": "0.1%"
    },
    "Ulcerative colitis": {
        "Primary organ/body part affected": "Colon and rectum",
        "Autoantibodies": "pANCA, ASCA",
        "Acceptance as an autoimmune disease": "Probable",
        "Prevalence rate (US)": "249 per 100,000 adults"
    },
    "Rheumatic heart disease": {
        "Primary organ/body part affected": "Heart valves",
        "Autoantibodies": "Anti-streptolysin O (ASO), anti-DNase B",
        "Acceptance as an autoimmune disease": "Confirmed",
        "Prevalence rate (US)": "Declining due to improved treatment of strep throat"
    },
    "Kawasaki disease": {
        "Primary organ/body part affected": "Coronary arteries",
        "Autoantibodies": "Unknown",
        "Acceptance as an autoimmune disease": "Probable",
        "Prevalence rate (US)": "20 per 100,000 children under age 5"
    },
    "Giant cell arteritis": {
        "Primary organ/body part affected": "Large and medium arteries, can affect coronary arteries",
        "Autoantibodies": "None specific",
        "Acceptance as an autoimmune disease": "Confirmed",
        "Prevalence rate (US)": "200 per 100,000 (over age 50)"
    },
    "Takayasu's arteritis": {
        "Primary organ/body part affected": "Large arteries, including the aorta",
        "Autoantibodies": "None specific",
        "Acceptance as an autoimmune disease": "Confirmed",
        "Prevalence rate (US)": "Rare, more common in East Asia"
    },
    "Behcet's disease": {
        "Primary organ/body part affected": "Small to large vessels in mouth, genitals, eyes, skin",
        "Autoantibodies": "None specific",
        "Acceptance as an autoimmune disease": "Probable",
        "Prevalence rate (US)": ""
    },
    "Eosinophilic granulomatosis with polyangiitis (EGPA)": {
        "Primary organ/body part affected": "See vascular system  [b]",
        "Autoantibodies": "See vascular system",
        "Acceptance as an autoimmune disease": "Confirmed",
        "Prevalence rate (US)": "See vascular system"
    },
    "Granulomatosis with polyangiitis (GPA)": {
        "Primary organ/body part affected": "See vascular system  [c]",
        "Autoantibodies": "See vascular system",
        "Acceptance as an autoimmune disease": "Confirmed",
        "Prevalence rate (US)": "See vascular system"
    },
    "IgA vasculitis (IgAV)": {
        "Primary organ/body part affected": "Small vessels in skin, joints, kidneys, gastrointestinal tract",
        "Autoantibodies": "IgA immune complexes",
        "Acceptance as an autoimmune disease": "Probable",
        "Prevalence rate (US)": ""
    },
    "Leukocytoclastic vasculitis": {
        "Primary organ/body part affected": "Small vessels in skin",
        "Autoantibodies": "Various immune complexes",
        "Acceptance as an autoimmune disease": "Probable",
        "Prevalence rate (US)": ""
    },
    "Lupus vasculitis": {
        "Primary organ/body part affected": "Small to medium vessels in multiple organs",
        "Autoantibodies": "ANA, anti-dsDNA, anti-Smith, others",
        "Acceptance as an autoimmune disease": "Confirmed",
        "Prevalence rate (US)": ""
    },
    "Rheumatoid vasculitis": {
        "Primary organ/body part affected": "Small to medium vessels in skin, nerves, eyes, heart",
        "Autoantibodies": "Rheumatoid factor, ACPA",
        "Acceptance as an autoimmune disease": "Probable",
        "Prevalence rate (US)": ""
    },
    "Microscopic polyangiitis (MPA)": {
        "Primary organ/body part affected": "Small vessels in kidneys, lungs, nerves, skin",
        "Autoantibodies": "p-ANCA/MPO-ANCA",
        "Acceptance as an autoimmune disease": "Confirmed",
        "Prevalence rate (US)": ""
    },
    "Polyarteritis nodosa (PAN)": {
        "Primary organ/body part affected": "Medium to small vessels in kidneys, skin, muscles, joints, nerves",
        "Autoantibodies": "None specific",
        "Acceptance as an autoimmune disease": "Probable",
        "Prevalence rate (US)": ""
    },
    "Polymyalgia rheumatica": {
        "Primary organ/body part affected": "Large to medium vessels in shoulders, hips",
        "Autoantibodies": "None specific",
        "Acceptance as an autoimmune disease": "Possible",
        "Prevalence rate (US)": ""
    },
    "Urticarial vasculitis": {
        "Primary organ/body part affected": "Small vessels in skin",
        "Autoantibodies": "C1q antibodies",
        "Acceptance as an autoimmune disease": "Probable",
        "Prevalence rate (US)": ""
    },
    "Vasculitis": {
        "Primary organ/body part affected": "All vessel sizes in multiple organs",
        "Autoantibodies": "Depends on specific type",
        "Acceptance as an autoimmune disease": "Uncertain",
        "Prevalence rate (US)": ""
    },
    "Goodpasture syndrome": {
        "Primary organ/body part affected": "See urinary system  [a]",
        "Autoantibodies": "See urinary system",
        "Acceptance as an autoimmune disease": "Confirmed",
        "Prevalence rate (US)": "See urinary system"
    },
    "IgA nephropathy": {
        "Primary organ/body part affected": "Kidneys",
        "Autoantibodies": "IgA autoantibodies",
        "Acceptance as an autoimmune disease": "Confirmed",
        "Prevalence rate (US)": "3.5 per 100,000"
    },
    "Membranous nephropathy": {
        "Primary organ/body part affected": "Kidneys",
        "Autoantibodies": "Anti-PLA2R antibodies",
        "Acceptance as an autoimmune disease": "Confirmed",
        "Prevalence rate (US)": "10 per 100,000"
    },
    "Lupus nephritis": {
        "Primary organ/body part affected": "Kidneys",
        "Autoantibodies": "Anti-dsDNA, Anti-Sm, Anti-nuclear antibodies",
        "Acceptance as an autoimmune disease": "Confirmed",
        "Prevalence rate (US)": "Up to 60% of those with Lupus"
    },
    "Interstitial nephritis": {
        "Primary organ/body part affected": "Kidneys",
        "Autoantibodies": "Various autoantibodies",
        "Acceptance as an autoimmune disease": "Probable",
        "Prevalence rate (US)": "Varies widely, often drug-induced"
    },
    "Interstitial cystitis": {
        "Primary organ/body part affected": "Bladder",
        "Autoantibodies": "Anti-urothelial and anti-nuclear antibodies",
        "Acceptance as an autoimmune disease": "Probable",
        "Prevalence rate (US)": "100-450 per 100,000 women, less common in men"
    },
    "Primary sclerosing cholangitis": {
        "Primary organ/body part affected": "Bile ducts, can affect gallbladder",
        "Autoantibodies": "P-ANCA, Anti Smooth Muscle Antibodies (ASMA)",
        "Acceptance as an autoimmune disease": "Confirmed",
        "Prevalence rate (US)": "1 per 100,000"
    },
    "Acute disseminated encephalomyelitis": {
        "Primary organ/body part affected": "Central nervous system",
        "Autoantibodies": "Unknown",
        "Acceptance as an autoimmune disease": "Confirmed",
        "Prevalence rate (US)": "0.8 per 100,000"
    },
    "Acute motor axonal neuropathy": {
        "Primary organ/body part affected": "Peripheral nerves",
        "Autoantibodies": "Anti-GM1",
        "Acceptance as an autoimmune disease": "Confirmed",
        "Prevalence rate (US)": "Part of Guillain-Barre syndrome prevalence"
    },
    "Anti-NMDA receptor encephalitis": {
        "Primary organ/body part affected": "Brain",
        "Autoantibodies": "Anti-NMDA receptor",
        "Acceptance as an autoimmune disease": "Confirmed",
        "Prevalence rate (US)": "1.5 per million"
    },
    "Autoimmune encephalitis": {
        "Primary organ/body part affected": "Brain",
        "Autoantibodies": "Various, depending on subtype (e.g., NMDA receptor antibodies, LGI1 antibodies)",
        "Acceptance as an autoimmune disease": "Confirmed",
        "Prevalence rate (US)": "Rare"
    },
    "Balo concentric sclerosis": {
        "Primary organ/body part affected": "Central nervous system",
        "Autoantibodies": "Unknown",
        "Acceptance as an autoimmune disease": "Probable",
        "Prevalence rate (US)": "Rare"
    },
    "Bickerstaff's encephalitis": {
        "Primary organ/body part affected": "Brain",
        "Autoantibodies": "Anti-GQ1b",
        "Acceptance as an autoimmune disease": "Confirmed",
        "Prevalence rate (US)": "Rare"
    },
    "Chronic inflammatory demyelinating polyneuropathy": {
        "Primary organ/body part affected": "Peripheral nerves",
        "Autoantibodies": "Various, including anti-MAG",
        "Acceptance as an autoimmune disease": "Confirmed",
        "Prevalence rate (US)": "1-2 per 100,000"
    },
    "Guillain-Barre syndrome": {
        "Primary organ/body part affected": "Peripheral nerves",
        "Autoantibodies": "Various, including anti-GM1, anti-GD1a",
        "Acceptance as an autoimmune disease": "Confirmed",
        "Prevalence rate (US)": "1-2 per 100,000"
    },
    "Hashimoto's encephalopathy": {
        "Primary organ/body part affected": "Brain",
        "Autoantibodies": "Anti-thyroid (TPO, Tg)",
        "Acceptance as an autoimmune disease": "Probable",
        "Prevalence rate (US)": "Rare"
    },
    "Idiopathic inflammatory demyelinating diseases": {
        "Primary organ/body part affected": "Central nervous system",
        "Autoantibodies": "Varies",
        "Acceptance as an autoimmune disease": "Probable",
        "Prevalence rate (US)": "Varies by specific disease"
    },
    "Lambert-Eaton myasthenic syndrome": {
        "Primary organ/body part affected": "Neuromuscular junction (affecting both CNS and PNS)",
        "Autoantibodies": "Anti-VGCC",
        "Acceptance as an autoimmune disease": "Confirmed",
        "Prevalence rate (US)": "0.5-2 per million"
    },
    "Multiple sclerosis": {
        "Primary organ/body part affected": "Central nervous system",
        "Autoantibodies": "Unknown, but Oligoclonal bands often present in CSF",
        "Acceptance as an autoimmune disease": "Confirmed",
        "Prevalence rate (US)": "90 per 100,000"
    },
    "Myasthenia gravis": {
        "Primary organ/body part affected": "Neuromuscular junction (affecting both CNS and PNS)",
        "Autoantibodies": "Anti-AChR, anti-MuSK",
        "Acceptance as an autoimmune disease": "Confirmed",
        "Prevalence rate (US)": "20 per 100,000"
    },
    "Neuromyelitis optica (Devic's disease)/NMOSD": {
        "Primary organ/body part affected": "Optic nerves and spinal cord",
        "Autoantibodies": "AQP4-IgG (NMO-IgG)",
        "Acceptance as an autoimmune disease": "Confirmed",
        "Prevalence rate (US)": "0.5 - 4 per 100,000"
    },
    "Restless legs syndrome": {
        "Primary organ/body part affected": "Central nervous system (thought to involve dopaminergic pathways)",
        "Autoantibodies": "Unknown",
        "Acceptance as an autoimmune disease": "Uncertain",
        "Prevalence rate (US)": "5-15% (more common in older adults)"
    },
    "Stiff-person syndrome": {
        "Primary organ/body part affected": "Central nervous system",
        "Autoantibodies": "Anti-GAD, anti-amphiphysin",
        "Acceptance as an autoimmune disease": "Confirmed",
        "Prevalence rate (US)": "Rare"
    },
    "Sydenham's chorea": {
        "Primary organ/body part affected": "Brain",
        "Autoantibodies": "Anti-basal ganglia",
        "Acceptance as an autoimmune disease": "Confirmed",
        "Prevalence rate (US)": "Rare (linked to Group A streptococcal infection)"
    },
    "Transverse myelitis": {
        "Primary organ/body part affected": "Spinal cord",
        "Autoantibodies": "Various, including anti-AQP4",
        "Acceptance as an autoimmune disease": "Probable",
        "Prevalence rate (US)": "1-8 per million"
    },
    "Undifferentiated connective tissue disease (UCTD)": {
        "Primary organ/body part affected": "Various",
        "Autoantibodies": "ANA (antinuclear autoantibody) (HEp-2 cells)",
        "Acceptance as an autoimmune disease": "Confirmed",
        "Prevalence rate (US)": "2 per 100,000"
    },
    "Addison's disease": {
        "Primary organ/body part affected": "Adrenal glands",
        "Autoantibodies": "21-hydroxylase antibodies",
        "Acceptance as an autoimmune disease": "Confirmed",
        "Prevalence rate (US)": "0.93-1.4 per 10,000"
    },
    "Autoimmune oophoritis": {
        "Primary organ/body part affected": "Ovaries",
        "Autoantibodies": "Anti-ovarian antibodies",
        "Acceptance as an autoimmune disease": "Probable",
        "Prevalence rate (US)": "Not well established"
    },
    "Autoimmune orchitis": {
        "Primary organ/body part affected": "Testes",
        "Autoantibodies": "Anti-sperm antibodies",
        "Acceptance as an autoimmune disease": "Probable",
        "Prevalence rate (US)": "Not well established"
    },
    "Autoimmune pancreatitis": {
        "Primary organ/body part affected": "Pancreas",
        "Autoantibodies": "IgG4, Anti-CA2 antibodies",
        "Acceptance as an autoimmune disease": "Confirmed",
        "Prevalence rate (US)": "0.82-1.3 per 100,000"
    },
    "Autoimmune polyendocrine syndrome type 1 (APS1)": {
        "Primary organ/body part affected": "Multiple endocrine organs",
        "Autoantibodies": "Various autoantibodies depending on the organs affected",
        "Acceptance as an autoimmune disease": "Confirmed",
        "Prevalence rate (US)": "1 in 100,000 to 200,000"
    },
    "Autoimmune polyendocrine syndrome type 2 (APS2)": {
        "Primary organ/body part affected": "Multiple endocrine organs",
        "Autoantibodies": "Various autoantibodies depending on the organs affected",
        "Acceptance as an autoimmune disease": "Confirmed",
        "Prevalence rate (US)": "1 in 20,000"
    },
    "Autoimmune polyendocrine syndrome type 3 (APS3)": {
        "Primary organ/body part affected": "Multiple endocrine organs",
        "Autoantibodies": "Various autoantibodies depending on the organs affected",
        "Acceptance as an autoimmune disease": "Confirmed",
        "Prevalence rate (US)": "Rare"
    },
    "Diabetes mellitus type 1": {
        "Primary organ/body part affected": "Pancreas",
        "Autoantibodies": "Anti-insulin, anti-IA-2, anti-GAD, anti-ZnT8 antibodies",
        "Acceptance as an autoimmune disease": "Confirmed",
        "Prevalence rate (US)": "1.6 per 1,000"
    },
    "Endometriosis": {
        "Primary organ/body part affected": "Uterus, ovaries, and pelvic tissue",
        "Autoantibodies": "Various, including anti-endometrial antibodies",
        "Acceptance as an autoimmune disease": "Probable",
        "Prevalence rate (US)": "Approx. 10% of women of reproductive age"
    },
    "Graves' disease": {
        "Primary organ/body part affected": "Thyroid gland",
        "Autoantibodies": "TSI, TPO, TG antibodies",
        "Acceptance as an autoimmune disease": "Confirmed",
        "Prevalence rate (US)": "1.2% of the population"
    },
    "Hashimoto's thyroiditis": {
        "Primary organ/body part affected": "Thyroid gland",
        "Autoantibodies": "TPO, TG antibodies",
        "Acceptance as an autoimmune disease": "Confirmed",
        "Prevalence rate (US)": "5% of the population"
    },
    "Ord's thyroiditis": {
        "Primary organ/body part affected": "Thyroid gland",
        "Autoantibodies": "TPO, TG antibodies",
        "Acceptance as an autoimmune disease": "Confirmed",
        "Prevalence rate (US)": "Rare"
    },
    "Sjogren syndrome": {
        "Primary organ/body part affected": "Exocrine glands (salivary and lacrimal glands)",
        "Autoantibodies": "Anti-SSA/Ro, Anti-SSB/La antibodies",
        "Acceptance as an autoimmune disease": "Confirmed",
        "Prevalence rate (US)": "0.1-4% of the population"
    },
    "Idiopathic pulmonary fibrosis": {
        "Primary organ/body part affected": "Lungs",
        "Autoantibodies": "None specific",
        "Acceptance as an autoimmune disease": "Possible",
        "Prevalence rate (US)": "20 per 100,000 (men), 13 per 100,000 (women)"
    },
    "Interstitial lung disease": {
        "Primary organ/body part affected": "Lungs",
        "Autoantibodies": "Depends on the subtype (e.g. Anti-Jo1 in Anti-synthetase syndrome)",
        "Acceptance as an autoimmune disease": "Probable",
        "Prevalence rate (US)": "31.5 per 100,000 (men), 26.1 per 100,000 (women)"
    },
    "Pulmonary alveolar proteinosis": {
        "Primary organ/body part affected": "Lungs",
        "Autoantibodies": "Anti-GM-CSF antibodies",
        "Acceptance as an autoimmune disease": "Confirmed",
        "Prevalence rate (US)": "6.2 per million"
    },
    "Rheumatoid lung disease": {
        "Primary organ/body part affected": "Lungs",
        "Autoantibodies": "Rheumatoid factor, Anti-CCP antibodies",
        "Acceptance as an autoimmune disease": "Confirmed",
        "Prevalence rate (US)": "Part of RA prevalence (about 1%)"
    },
    "Sarcoidosis": {
        "Primary organ/body part affected": "Lungs and other organs",
        "Autoantibodies": "None specific",
        "Acceptance as an autoimmune disease": "Confirmed",
        "Prevalence rate (US)": "10 - 40 per 100,000"
    },
    "Autoimmune hemolytic anemia": {
        "Primary organ/body part affected": "Anti-red blood cell antibodies",
        "Autoantibodies": "Confirmed",
        "Acceptance as an autoimmune disease": "1-3 per 100,000",
        "Prevalence rate (US)": "[89]"
    },
    "Immune thrombocytopenia": {
        "Primary organ/body part affected": "Anti-platelet antibodies",
        "Autoantibodies": "Confirmed",
        "Acceptance as an autoimmune disease": "3.3 per 100,000 (adults), 50 per 100,000 (children)",
        "Prevalence rate (US)": "[90]"
    },
    "Thrombotic thrombocytopenic purpura": {
        "Primary organ/body part affected": "ADAMTS13 autoantibodies",
        "Autoantibodies": "Confirmed",
        "Acceptance as an autoimmune disease": "1-2 per million",
        "Prevalence rate (US)": "[91]"
    },
    "Antiphospholipid syndrome": {
        "Primary organ/body part affected": "Antiphospholipid antibodies",
        "Autoantibodies": "Confirmed",
        "Acceptance as an autoimmune disease": "40-50 per 100,000",
        "Prevalence rate (US)": "[92]"
    },
    "Paroxysmal nocturnal hemoglobinuria": {
        "Primary organ/body part affected": "None specific, mutation causes self-cells to become susceptible to attack",
        "Autoantibodies": "Possible",
        "Acceptance as an autoimmune disease": "1-2 per million",
        "Prevalence rate (US)": "[93]"
    },
    "Premature ovarian failure": {
        "Primary organ/body part affected": "Ovaries",
        "Autoantibodies": "Anti-ovarian antibodies, Anti-adrenal antibodies",
        "Acceptance as an autoimmune disease": "Confirmed",
        "Prevalence rate (US)": "1% of women under 40 years"
    },
    "Autoimmune retinopathy": {
        "Primary organ/body part affected": "Retina",
        "Autoantibodies": "Various",
        "Acceptance as an autoimmune disease": "Confirmed",
        "Prevalence rate (US)": ""
    },
    "Autoimmune uveitis": {
        "Primary organ/body part affected": "Uvea",
        "Autoantibodies": "Various",
        "Acceptance as an autoimmune disease": "Confirmed",
        "Prevalence rate (US)": ""
    },
    "Cogan syndrome": {
        "Primary organ/body part affected": "Inner ear and eye",
        "Autoantibodies": "None specific",
        "Acceptance as an autoimmune disease": "Probable",
        "Prevalence rate (US)": ""
    },
    "Graves' ophthalmopathy": {
        "Primary organ/body part affected": "Eye muscles and connective tissue",
        "Autoantibodies": "TSH receptor antibodies",
        "Acceptance as an autoimmune disease": "Confirmed",
        "Prevalence rate (US)": ""
    },
    "Intermediate uveitis": {
        "Primary organ/body part affected": "Uvea (pars plana)",
        "Autoantibodies": "Various",
        "Acceptance as an autoimmune disease": "Probable",
        "Prevalence rate (US)": ""
    },
    "Ligneous conjunctivitis": {
        "Primary organ/body part affected": "Conjunctiva",
        "Autoantibodies": "Plasminogen deficiency",
        "Acceptance as an autoimmune disease": "Possible",
        "Prevalence rate (US)": "Rare"
    },
    "Mooren's ulcer": {
        "Primary organ/body part affected": "Cornea",
        "Autoantibodies": "None specific",
        "Acceptance as an autoimmune disease": "Probable",
        "Prevalence rate (US)": "Rare"
    },
    "Neuromyelitis optica": {
        "Primary organ/body part affected": "Optic nerve and spinal cord",
        "Autoantibodies": "Anti-AQP4",
        "Acceptance as an autoimmune disease": "Confirmed",
        "Prevalence rate (US)": ""
    },
    "Opsoclonus myoclonus syndrome": {
        "Primary organ/body part affected": "Central nervous system, eye movement control",
        "Autoantibodies": "Anti-neuronal antibodies",
        "Acceptance as an autoimmune disease": "Possible",
        "Prevalence rate (US)": ""
    },
    "Optic neuritis": {
        "Primary organ/body part affected": "Optic nerve",
        "Autoantibodies": "Various",
        "Acceptance as an autoimmune disease": "Confirmed",
        "Prevalence rate (US)": ""
    },
    "Scleritis": {
        "Primary organ/body part affected": "Sclera",
        "Autoantibodies": "Various",
        "Acceptance as an autoimmune disease": "Possible",
        "Prevalence rate (US)": ""
    },
    "Susac's syndrome": {
        "Primary organ/body part affected": "Retina, cochlea, and brain",
        "Autoantibodies": "None specific",
        "Acceptance as an autoimmune disease": "Probable",
        "Prevalence rate (US)": ""
    },
    "Sympathetic ophthalmia": {
        "Primary organ/body part affected": "Uveal tract",
        "Autoantibodies": "Various",
        "Acceptance as an autoimmune disease": "Probable",
        "Prevalence rate (US)": "Rare"
    },
    "Tolosa-Hunt syndrome": {
        "Primary organ/body part affected": "Orbit",
        "Autoantibodies": "None specific",
        "Acceptance as an autoimmune disease": "Uncertain",
        "Prevalence rate (US)": "Rare"
    }
}